Despite its critical role for the production and release testing of cell products in modern cell therapies, flow cytometry remains a notoriously variable technique.
However, reproducibility and consistency are of key concern when monitoring cell production processes and releases of products, such as CAR T cell therapies. Therefore, it is essential that in-process control and quality control measures by flow cytometry fulfill essential standardization criteria.
Presenters: Kalpana Singh, Ph.D., Global Product Manager flow cytometry reagents, Miltenyi Biotec and Monika Maasem Panakova, Ph.D., Global Product Manager flow cytometry reagents, Miltenyi Biotec
This webinar took place on July, 2019.